Capsular polysaccharide of Cryptococcus neoformans induces proinflammatory cytokine release by human neutrophils.
about
Dancing cheek to cheek: Cryptococcus neoformans and phagocytesHost immunity to Cryptococcus neoformansCompartmentalization of neutrophils in the kidney and lung following acute ischemic kidney injury.Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection.Role of the Apt1 protein in polysaccharide secretion by Cryptococcus neoformans.Involvement of C3a and C5a in interleukin-8 secretion by human polymorphonuclear cells in response to capsular material of Cryptococcus neoformans.Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis.Cryptococcus neoformans responds to mannitol by increasing capsule size in vitro and in vivo.Cryptococcus neoformans induces macrophage inflammatory protein 1alpha (MIP-1alpha) and MIP-1beta in human microglia: role of specific antibody and soluble capsular polysaccharide.Cryptococcus neoformans capsular enlargement and cellular gigantism during Galleria mellonella infection.Immunoglobulin G monoclonal antibodies to Cryptococcus neoformans protect mice deficient in complement component C3Modulation of C5aR expression on human neutrophils by encapsulated and acapsular Cryptococcus neoformans.Binding and internalization of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, by murine peritoneal macrophagesDepletion of neutrophils in a protective model of pulmonary cryptococcosis results in increased IL-17A production by γδ T cells.Evidence for branching in cryptococcal capsular polysaccharides and consequences on its biological activity.Junctional adhesion molecule-A regulates vascular endothelial growth factor receptor-2 signaling-dependent mouse corneal wound healing.In vivo role of dendritic cells in a murine model of pulmonary cryptococcosisThe role of host gender in the pathogenesis of Cryptococcus neoformans infections.Modulation of polymorphonuclear cell interleukin-8 secretion by human monoclonal antibodies to type 8 pneumococcal capsular polysaccharideSecretion of the C3 component of complement by peritoneal cells cultured with encapsulated Cryptococcus neoformans.Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infectionSTAT1 signaling within macrophages is required for antifungal activity against Cryptococcus neoformansInduction of capsule growth in Cryptococcus neoformans by mammalian serum and CO(2).Evasion of Innate Immune Responses by the Highly Virulent Cryptococcus gattii by Altering Capsule Glucuronoxylomannan StructureAltered immune response differentially enhances susceptibility to Cryptococcus neoformans and Cryptococcus gattii infection in mice expressing the HIV-1 transgene.A Glucuronoxylomannan-Associated Immune Signature, Characterized by Monocyte Deactivation and an Increased Interleukin 10 Level, Is a Predictor of Death in Cryptococcal Meningitis.Cytokine and inducible nitric oxide synthase mRNA expression during experimental murine cryptococcal meningoencephalitis.The capsule of the fungal pathogen Cryptococcus neoformans.Cryptococcus gattii isolates from the British Columbia cryptococcosis outbreak induce less protective inflammation in a murine model of infection than Cryptococcus neoformans.Fungal surface and innate immune recognition of filamentous fungi.Immunity to Cryptococcus neoformans and C. gattii during cryptococcosisCytokine profiles of AIDS patients are similar to those of mice with disseminated Cryptococcus neoformans infection.Encapsulation of Cryptococcus neoformans with glucuronoxylomannan inhibits the antigen-presenting capacity of monocytes.Antibody-mediated protection in murine Cryptococcus neoformans infection is associated with pleotrophic effects on cytokine and leukocyte responses.Cryptococcal glucuronoxylomannan inhibits adhesion of neutrophils to stimulated endothelium in vitro by affecting both neutrophils and endothelial cells.Antigenic and biological characteristics of mutant strains of Cryptococcus neoformans lacking capsular O acetylation or xylosyl side chains.Prospects for the development of fungal vaccines.Interleukin-6 production by human monocytes stimulated with Cryptococcus neoformans components.Neutrophil swarming toward Cryptococcus neoformans is mediated by complement and leukotriene B4.What makes Cryptococcus neoformans a pathogen?
P2860
Q26798926-E2317945-3BE5-4063-8AAC-CA42B1A8935DQ26823438-E89AD620-A262-40DC-9049-5795412B883AQ30436624-1F1D3794-0603-40C3-8FC6-7FF0CEF4F1EAQ33598508-128DC771-A160-4146-A33D-ABFA97068E69Q33743568-7ED6C554-EFC3-4B2F-A3E2-69F1BE867846Q33762293-4F865D0A-4134-4650-9EF9-E682C644DDDEQ33857658-24705D85-0BFA-4AA9-AA28-FA1671DFA30DQ33939999-79DD0C6C-3A61-4D18-9711-8F491BF131B9Q34006498-F7B810E1-0CA5-4EFA-B2F5-D125EA5611E3Q34019066-AC7C389C-E534-46F4-B02E-CFDADB24D409Q34121516-1342D30E-39D0-428F-9E2D-C14525899393Q34125581-91CDCC64-D2CF-4DBE-9ACA-D873CD2D988BQ34301177-D058D7E4-AABF-4635-A0DF-6D00C9634DF5Q34502561-F4302192-227C-41FD-AAC2-354BDA337644Q34561087-B4F3634D-770B-4CC6-8ACD-C1364C7C1DAFQ34718345-32E52B5F-F662-4A0B-A4BB-1DB030828F5DQ34721052-BB0651B3-0DA6-470E-9CF2-EF215DC3521BQ34760386-2DD70C39-22A6-4DD6-967D-83350D154C5DQ34940688-53F2B6A0-D1A1-415F-A4A8-8344FB54CF74Q35556339-B93BDD7E-4744-4D6D-9AA7-E6A71A1D439FQ36042949-B720EB80-833D-4DAA-AD25-DBA1D4E602D8Q36281328-43859AED-9327-4EC7-85F2-7C23317BE7B7Q36376167-D1C8D8BE-1987-4E88-8C0F-7D43BB6CE896Q36431950-A6485275-7A3F-459E-9D94-DAD7DA359AB1Q36804765-BB3AC27E-2544-466E-A0C8-62154485C88EQ36871924-DFF08CB5-9F64-40B1-A00C-D55286577100Q37115803-A05D81CC-EA5F-49BE-BC00-06AAB9EBF89DQ37337879-343073DB-969F-4CDA-8045-BF4461D64ECEQ37355898-3D899D44-2C9E-4138-A94C-C6105D5FE640Q37971025-8B3E831F-5908-49CF-B191-2FF9ED5EF8CAQ38286732-76355262-B8A1-438A-A5CC-99D0FE3B5479Q39513175-0F04BC9A-D9AD-412B-9730-3B0D7886C754Q39569976-D3A8C705-0010-4C46-8D89-856E9F630F00Q39654344-C1160DD4-7E13-493C-8771-89A8F7CE1358Q39656137-C97B5C8D-5C53-432C-B0AD-8A263D024431Q39746326-05DE0296-F3E8-4A67-8898-6D5DD46B6BCBQ39820834-5652C0AE-782B-4000-830B-0DF5C996970EQ39830210-2D46896D-52B8-46F0-A24A-2D7A04E3EFE7Q40617677-F630AC67-A1A9-4347-9DB7-D84642A0B62BQ41695186-56AB230A-2DDD-4BEA-85CA-E3462311C83C
P2860
Capsular polysaccharide of Cryptococcus neoformans induces proinflammatory cytokine release by human neutrophils.
description
1996 nî lūn-bûn
@nan
1996 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Capsular polysaccharide of Cry ...... release by human neutrophils.
@ast
Capsular polysaccharide of Cry ...... release by human neutrophils.
@en
type
label
Capsular polysaccharide of Cry ...... release by human neutrophils.
@ast
Capsular polysaccharide of Cry ...... release by human neutrophils.
@en
prefLabel
Capsular polysaccharide of Cry ...... release by human neutrophils.
@ast
Capsular polysaccharide of Cry ...... release by human neutrophils.
@en
P2093
P2860
P1476
Capsular polysaccharide of Cry ...... release by human neutrophils.
@en
P2093
P2860
P304
P407
P577
1996-08-01T00:00:00Z